Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 15-12G

Assertio Holdings, Inc.

SEC Filing

Filed Jul 31, 2026Accepted Jul 31, 2026, 1:32 PM EDTCIK 1808665Accession 0001104659-26-089132
Share

Company context

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products primarily in the oncology market. To learn more about Assertio, visit www.assertiotx.com.

Historical securities (1)

Recent company filings

  1. 25-NSE - filed by Nasdaq Stock Market LLC regarding Assertio Holdings, Inc.Jul 7, 2026
  2. 15-12G filingJun 26, 2026
  3. EFFECT filingJun 17, 2026
  4. EFFECT filingJun 17, 2026
  5. EFFECT filingJun 17, 2026

As-filed source

Primary evidence